Kirke Weaver - 31 Mar 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role: Gen. Counsel & Corp. Secy.
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Kirke Weaver
Issuer symbol: OGN
Transactions as of: 31 Mar 2023
Net transactions value: -$48,835
Form type: 4
Filing time: 04 Apr 2023, 20:21:54 UTC
Previous filing: 02 Mar 2023
Next filing: 03 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise	$0	+7,419	+135%	$0.000000	12,900	31 Mar 2023	Direct
transaction	OGN	Common Stock	Tax liability	$48,835	-2,115	-16%	$23.09	10,785	31 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-7,419	-33%	$0.000000	14,838	31 Mar 2023	Common Stock	7,419		Direct	F1, F2
transaction	OGN	Stock Option (right to buy)	Award	$0	+66,793		$0.000000	66,793	31 Mar 2023	Common Stock	66,793	$23.52	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F2	On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025.
F3	The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026.